Stamford Hospital partakes in trial of breakthrough breast cancer medication
Breast cancer doctors and patients are ecstatic that trials of a new drug were called off because the medication proved to be so successful. Breast cancer survivor Joyce Petre just found out she's been taking the breakthrough breast cancer drug Letrozole, brand name Femara, for two and a half years. Dr. Steven Lo says Joyce is one of nine Stamford Hospital patients who've been part of the national clinical trial the medication, with four patients on Letrozol and five on the placebo. Experts say the medication is killing cancer cells not destroyed by chemo or Tamoxifen. Based on the study of 5,000 women, those who got Letrozole had about half as many cancer recurrences than women who didn't.